We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in preventing venous thrombosis after total knee arthroplasty. In this randomized, double-blind trial, 2531 ...
Unlike unfractionated heparin (UFH), the low-molecular-weight heparin enoxaparin (Lovenox) is excreted mainly by the kidneys. To determine whether this characteristic heightens bleeding risk in ...
July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...
LANGHORNE, Pa.--(BUSINESS WIRE)--#Enoxaparin--Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the launch of its 30mg, ...
If you have deep vein thrombosis or a pulmonary embolism, or if you had a certain kind of heart attack (among other conditions), your doctor may prescribe the blood thinner enoxaparin (Lovenox), per ...
Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
“We are very excited to bring our enoxaparin biosimilars Inclunox ® and Inclunox ® HP to market by building on our worldwide experience with biosimilars. The enoxaparin biosimilar market represents ...
This phase 3 trial compared the efficacy and safety of rivaroxaban, an oral direct inhibitor of factor Xa, with those of enoxaparin for extended thromboprophylaxis in patients undergoing total hip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback